Molecular Diagnostics Market
To learn more about this report, request a free sample copy
Molecular Diagnostics Market Overview
The report is titled ‘Molecular Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Molecular Diagnostics market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The Molecular Diagnostics market is expected to grow at a significant rate in the near future.
The global Molecular Diagnostics market is estimated to reach at a value of US$ 9.8 Bn by the end of 2020 and expected to reach at a value of US$ xx Bn by 2028 with a significant CAGR of 8.7%
Molecular Diagnostics Introduction
Molecular diagnostics, also commonly known as molecular pathology, can be comprehended as a medical procedure that comprises taking samples of DNA or RNA from an individual’s body, which is a exclusive genetic code found in human cells, and examining the patterns for danger signs that can identify and diagnose the probable emergence of a specific ailment. The molecular diagnostic tests are usually performed to figure out whether or not patients have a gene mutation related with a specific ailment, either as an hereditary or a captured mutation. The test can also be performed to determine a common inherited hereditary cancer. Hereditary disorders can be determined at the newborn, prenatal, and adult stages of life.
In addition, the molecular diagnostics test is also performed when there is a need to determine whether a patient has become immune or resistant to a specific drug and needs to change or replace course in a clinical regime. For instance, an HIV patient can be observed by a quantitative molecular test to identify whether or not the viral load of the specific disease has considerably surged, which is an indication of resistance to the medical treatment. The patient’s HIV can further be DNA sequenced to identify if the mutation which is considered to be related with resistance is found.
Molecular Diagnostics Market Dynamics
There are abundant strong driving factors owing to which the global molecular diagnostics market is projected to witness significant growth in the coming years. One of the key factors that is majorly boosting the growth of the global molecular diagnostics industry is the invariably increasing incidence of infectious diseases, including HPV, influenza, HIV, hepatitis, and tuberculosis as well as different types of cancers among the population across the world.
Conventionally, the antimicrobial therapeutics is adopted for treating infectious diseases, however, the molecular diagnostics are strongly replacing convention methods due to the fact that conventional methods are not competent enough to combat the emergence of drug-resistant pathogens and viruses. Such factors are also strongly strengthening the growth of the global molecular diagnostics market.
In addition, there have been numerous technological advances in the area of molecular diagnostics which further escalates its potential and makes it competent enough to diagnose, prevent, and treat various chronic disorders and diseases effectively, which positively fuels the growth of the global molecular diagnostics market in the forthcoming years.
Moreover, the rising prevalence of cancer, globally, is also expected to give a positive push to the growth of the global molecular diagnostics market in the years to come. However, the legal and regulatory requirements for the molecular diagnostics are becoming stringent day after day, which is likely to act as a restraining factor for the growth of the global molecular diagnostics market over the forecast period. Furthermore, the high cost of disease diagnostics is also anticipated to hold the growth of the global market molecular diagnostics to the bounds.
Nevertheless, the rising trend of Point of Care diagnostics in the global market is estimated to accelerate the growth of the global molecular diagnostics market in the near future. In addition to that, there is a soaring number of R&D initiatives in developing economies, at present, which further positively fuels the growth of the global molecular diagnostics market.
Molecular Diagnostics Market Segmentation
The global molecular diagnostics market is segmented on the basis of product & services, technology, application, end-users and region. On the basis of the product & services, the molecular diagnostics market is segmented into Reagents & Kits, instruments, and software & services. On the basis of technology, the market is divided into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and NGS, DNA Microarrays, In Situ Hybridization, and Other Technologies. On the basis of application, the market is segmented into Infectious Disease, Oncology, Genetic Tests, and Other Applications. Further, the market is segmented on the basis of end-users into Hospital and Academic Laboratories, Reference Laboratories, and Other End-Users.
The research report classifies the global molecular diagnostics market based on Product & Service, Technology, Application, End-User and regions.
By Product & Service
Reagents & Kits
Instruments
Software and Service
By Technology
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing and NGS
DNA Microarrays
In Situ Hybridization
Other Technologies
By Application
Infectious Disease
Oncology
Genetic Tests
Other Applications
By End-User
Hospital and Academic Laboratories
Reference Laboratories
Other End-Users
Molecular Diagnostics Market Key Players
The global molecular diagnostics market is dominated by Abbott Laboratories, Becton, Dickinson, and Company & Biomérieux Sa & Danaher Corporation, QIAGEN N.V. & among others.
MMC Overview on Molecular Diagnostics Market Report
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the molecular diagnostics market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of Molecular Diagnostics
Advantages of Molecular Diagnostics
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market
To learn more about this report, request a free sample copy
1. Global Molecular Diagnostics Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Molecular Diagnostics Market Overview
2.1. Introduction
2.1.1. Introduction
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Molecular Diagnostics Market Snapshot
2.4. Global Molecular Diagnostics Market Size And Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Molecular Diagnostics Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Porter’s Five Forces Model
2.7. SWOT Analysis
3. Molecular Diagnostics Assessment and Analysis
3.1. Molecular Diagnostics Impact Analysis
3.2. Actions to encourage use of MUSIC STREAMING SERVICES
3.3. Molecular Diagnostics Promotional Strategy Recommendation
3.4. Road Map Analysis
3.5. GAP Analysis
3.6. Potential Analysis
4. Covid-19 Impact on Molecular Diagnostics Market
4.1. Impact Analysis of Covid-19 on the global Molecular Diagnostics market
4.2. Effect On Value Chain
4.3. Business Impact W.R.T Revenue
4.4. Volatility In Price
4.5. Effect On The Overall Trade
4.6. Market Impact Analysis In 2020 (Quarter Wise)
5. Global Molecular Diagnostics Market, By Product & Services
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Product & Services
5.1.2. BPS Analysis, By Product & Services
5.2. Market Revenue (US$Mn) and Forecast, By Product & Services
5.2.1. Reagents & Kits
5.2.2. Instruments
5.2.3. Software and Service
5.3. Global Molecular Diagnostics Market Attractiveness Index, By Product & Services
6. Global Molecular Diagnostics Market, By Technology
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Technology
6.1.2. BPS Analysis, By Technology
6.2. Market Revenue (US$Mn) and Forecast, By Technology
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.2.3. DNA Sequencing and NGS
6.2.4. DNA Microarrays
6.2.5. In Situ Hybridization
6.2.6. Other Technologies
6.3. Global Molecular Diagnostics Market Attractiveness Index, By Technology
7. Global Molecular Diagnostics Market, By Application
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Application
7.1.2. BPS Analysis, By Application
7.2. Market Revenue (US$Mn) and Forecast, By Application
7.2.1. Infectious Disease
7.2.2. Oncology
7.2.3. Genetic Tests
7.2.4. Other Applications
7.3. Global Molecular Diagnostics Market Attractiveness Index, By Application
8. Global Molecular Diagnostics Market, By End-User
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By End-User
8.1.2. BPS Analysis, By End-User
8.2. Market Revenue (US$Mn) and Forecast, By End-User
8.2.1. Hospital and Academic Laboratories
8.2.2. Reference Laboratories
8.2.3. Other End-Users
8.3. Global Molecular Diagnostics Market Attractiveness Index, By End-User
9. Global Molecular Diagnostics Market, By Region
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Region
9.1.2. BPS Analysis, By Region
9.2. Market Revenue (US$Mn) and Forecast, By Region
9.2.1. North America
9.2.2. Latin America
9.2.3. Europe
9.2.4. Asia Pacific
9.2.5. Middle East
9.2.6. Africa
9.3. Global Molecular Diagnostics Market Attractiveness Index, By Region
10. North America Molecular Diagnostics Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market Revenue (US$Mn) and Forecast, By Country
10.2.1. U.S. Molecular Diagnostics Market
10.2.2. Canada Molecular Diagnostics Market
10.3. North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services
10.3.1. Reagents & Kits
10.3.2. Instruments
10.3.3. Software and Service
10.4. North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology
10.4.1. Polymerase Chain Reaction (PCR)
10.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.4.3. DNA Sequencing and NGS
10.4.4. DNA Microarrays
10.4.5. In Situ Hybridization
10.4.6. Other Technologies
10.5. North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application
10.5.1. Infectious Disease
10.5.2. Oncology
10.5.3. Genetic Tests
10.5.4. Other Applications
10.6. North America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User
10.6.1. Hospital and Academic Laboratories
10.6.2. Reference Laboratories
10.6.3. Other End-Users
10.7. North America Molecular Diagnostics Market Attractiveness Index
10.7.1. By Country
10.7.2. By Product & Services
10.7.3. By Technology
10.7.4. By Application
10.7.5. By End-User
11. Latin America Molecular Diagnostics Market Analysis and Forecast, 2020–2028
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. Brazil Molecular Diagnostics Market
11.2.2. Mexico Molecular Diagnostics Market
11.2.3. Rest Of Latin America Molecular Diagnostics Market
11.3. Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services
11.3.1. Reagents & Kits
11.3.2. Instruments
11.3.3. Software and Service
11.4. Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology
11.4.1. Polymerase Chain Reaction (PCR)
11.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
11.4.3. DNA Sequencing and NGS
11.4.4. DNA Microarrays
11.4.5. In Situ Hybridization
11.4.6. Other Technologies
11.5. Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application
11.5.1. Infectious Disease
11.5.2. Oncology
11.5.3. Genetic Tests
11.5.4. Other Applications
11.6. Latin America Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User
11.6.1. Hospital and Academic Laboratories
11.6.2. Reference Laboratories
11.6.3. Other End-Users
11.7. Latin America Molecular Diagnostics Market Attractiveness Index
11.7.1. By Country
11.7.2. By Product & Services
11.7.3. By Technology
11.7.4. By Application
11.7.5. By End-User
12. Europe Molecular Diagnostics Market Analysis and Forecast, 2020–2028
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. U.K. Molecular Diagnostics Market
12.2.2. Germany Molecular Diagnostics Market
12.2.3. Italy Molecular Diagnostics Market
12.2.4. France Molecular Diagnostics Market
12.2.5. Spain Molecular Diagnostics Market
12.2.6. Russia Molecular Diagnostics Market
12.2.7. Rest Of Europe Molecular Diagnostics Market
12.3. Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services
12.3.1. Reagents & Kits
12.3.2. Instruments
12.3.3. Software and Service
12.4. Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology
12.4.1. Polymerase Chain Reaction (PCR)
12.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
12.4.3. DNA Sequencing and NGS
12.4.4. DNA Microarrays
12.4.5. In Situ Hybridization
12.4.6. Other Technologies
12.5. Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application
12.5.1. Infectious Disease
12.5.2. Oncology
12.5.3. Genetic Tests
12.5.4. Other Applications
12.6. Europe Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User
12.6.1. Hospital and Academic Laboratories
12.6.2. Reference Laboratories
12.6.3. Other End-Users
12.7. Europe Molecular Diagnostics Market Attractiveness Index
12.7.1. By Country
12.7.2. By Product & Services
12.7.3. By Technology
12.7.4. By Application
12.7.5. By End-User
13. Asia Pacific Molecular Diagnostics Market Analysis and Forecast, 2020–2028
13.1. Introduction
13.1.1. Annual Growth Rate Comparison, By Country
13.1.2. BPS Analysis, By Country
13.2. Market (US$Mn) Forecast, By Country
13.2.1. China Molecular Diagnostics Market
13.2.2. India Molecular Diagnostics Market
13.2.3. Japan Molecular Diagnostics Market
13.2.4. Australia and New Zealand Molecular Diagnostics Market
13.2.5. South Korea Molecular Diagnostics Market
13.2.6. Rest of Asia Pacific Molecular Diagnostics Market
13.3. Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services
13.3.1. Reagents & Kits
13.3.2. Instruments
13.3.3. Software and Service
13.4. Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology
13.4.1. Polymerase Chain Reaction (PCR)
13.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
13.4.3. DNA Sequencing and NGS
13.4.4. DNA Microarrays
13.4.5. In Situ Hybridization
13.4.6. Other Technologies
13.5. Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application
13.5.1. Infectious Disease
13.5.2. Oncology
13.5.3. Genetic Tests
13.5.4. Other Applications
13.6. Asia Pacific Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User
13.6.1. Hospital and Academic Laboratories
13.6.2. Reference Laboratories
13.6.3. Other End-Users
13.7. Asia Pacific Molecular Diagnostics Market Attractiveness Index
13.7.1. By Country
13.7.2. By Product & Services
13.7.3. By Technology
13.7.4. By Application
13.7.5. By End-User
14. Middle East Molecular Diagnostics Market Analysis and Forecast, 2020–2028
14.1. Introduction
14.1.1. Annual Growth Rate Comparison, By Country
14.1.2. BPS Analysis, By Country
14.2. Market (US$Mn) Forecast, By Country
14.2.1. GCC Countries Molecular Diagnostics Market
14.2.2. Israel Molecular Diagnostics Market
14.2.3. Rest Of Middle East Molecular Diagnostics Market
14.3. Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services
14.3.1. Reagents & Kits
14.3.2. Instruments
14.3.3. Software and Service
14.4. Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology
14.4.1. Polymerase Chain Reaction (PCR)
14.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
14.4.3. DNA Sequencing and NGS
14.4.4. DNA Microarrays
14.4.5. In Situ Hybridization
14.4.6. Other Technologies
14.5. Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application
14.5.1. Infectious Disease
14.5.2. Oncology
14.5.3. Genetic Tests
14.5.4. Other Applications
14.6. Middle East Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User
14.6.1. Hospital and Academic Laboratories
14.6.2. Reference Laboratories
14.6.3. Other End-Users
14.7. Middle East Molecular Diagnostics Market Attractiveness Index
14.7.1. By Country
14.7.2. By Product & Services
14.7.3. By Technology
14.7.4. By Application
14.7.5. By End-User
15. Africa Molecular Diagnostics Market Analysis and Forecast, 2020–2028
15.1. Introduction
15.1.1. Annual Growth Rate Comparison, By Country
15.1.2. BPS Analysis, By Country
15.2. Market (US$Mn) Forecast, By Country
15.2.1. South Africa Countries Molecular Diagnostics Market
15.2.2. Egypt Molecular Diagnostics Market
15.2.3. North Africa Molecular Diagnostics Market
15.2.4. Rest of Africa Molecular Diagnostics Market
15.3. Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Product & Services
15.3.1. Reagents & Kits
15.3.2. Instruments
15.3.3. Software and Service
15.4. Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Technology
15.4.1. Polymerase Chain Reaction (PCR)
15.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
15.4.3. DNA Sequencing and NGS
15.4.4. DNA Microarrays
15.4.5. In Situ Hybridization
15.4.6. Other Technologies
15.5. Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By Application
15.5.1. Infectious Disease
15.5.2. Oncology
15.5.3. Genetic Tests
15.5.4. Other Applications
15.6. Africa Molecular Diagnostics Market Revenue (US$Mn) and Forecast, By End-User
15.6.1. Hospital and Academic Laboratories
15.6.2. Reference Laboratories
15.6.3. Other End-Users
15.7. Africa Molecular Diagnostics Market Attractiveness Index
15.7.1. By Country
15.7.2. By Product & Services
15.7.3. By Technology
15.7.4. By Application
15.7.5. By End-User
16. Competitive Landscape
16.1. Company Profiles
16.1.1. Abbott Laboratories
16.1.1.1. Company Overview
16.1.1.2. Financial Overview
16.1.1.3. Key Developments
16.1.1.4. Strategies
16.1.1.5. Product Analysis
16.1.2. QIAGEN N.V.
16.1.3. Becton
16.1.4. Dickinson and Company
16.1.5. Biomérieux Sa & Danaher Corporation
17. Acronyms
Select License Type
Frequently Asked Questions
The global molecular diagnostics market is estimated to reach at a value of US$ 9.8 Bn by the end of 2020 and expected to reach at a value of US$ xx Bn by 2028 with a significant CAGR of 8.7%
Invariably increasing incidence of infectious diseases, including HPV, influenza, HIV, hepatitis, and tuberculosis as well as different types of cancers among the population across the world. Technological advancement and increasing prevalence of cancer are also expected to fuel the growth of molecular diagnostics market
The global molecular diagnostics market is segmented on the basis of product & service, technology, application, end-user and regions.
The global molecular diagnostics market is dominated by Abbott Laboratories, Becton, Dickinson, and Company & Biomérieux Sa & Danaher Corporation, QIAGEN N.V. & among others.